Biotechnology

From spinning out Takeda’s China assets to acquiring South Korea’s Hugel, CBC is building a global M&A engine with execution at its core.

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

Baidu CEO’s life sciences startup sees artificial intelligence as the inevitable force driving transformation in drug discovery and biotech

A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.

Founder Wu Zhenhua explores the promise of gene therapy and its potential to reshape the future of medicine.

By leveraging DingTalk’s AI tools, Readline has managed to cut the cost of key skincare ingredients.

With no cure in sight for Alzheimer’s disease, caregivers struggle to weigh the odds of pursuing costly treatments.

2024 could see Chinese pharma matching up to global giants in the race for small nucleic acid drug breakthroughs.